Skip to main content

24 APRIL, 2012

bioMérieux - First-Quarter 2012 Business Review

  • Sales up 9.3% at constant exchange rates
    • Of which 3.1% organic growth, in line with objectives
  • Strong momentum* in China (up 47%) and India (up 31%)
  • Solid performance* in industrial applications (up 11.6%)
  • Significant operational advances
  • 2012 sales growth objective confirmed

* At constant exchange rates and comparable business base

Download

Filename
biomerieux_pr_sales_q1_2012_en.pdf
Size
263 KB
Format
application/pdf